
CTI and Spectrum form JV for marketing of Zevalin; ended
Executive Summary
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Joint Venture
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com